Long-term spaceflight not linked to major health risks: NASA 'Twins Study'

Image
IANS Washington
Last Updated : Feb 16 2019 | 1:00 PM IST

While it was previously thought that long duration spaceflight can affect the human body, even at the molecular level, new results from NASAs "Twins Study" has showed that there are no major warning signs and no reason to think humans cannot survive a two-and-a-half-year round-trip journey to Mars.

As part of the "Twins Study", NASA astronaut Scott Kelly spent a year in space while Mark, his identical twin, stayed on Earth as a control subject to look at the effects of space travel on the human body.

Spending nearly a year in orbit increased NASA astronaut Scott Kelly's immune system response, as if, at the cellular level, his body felt under attack as compared to his Earth-bound twin brother, the Washington Post reported on Friday.

These comparisons, however, has not raised any red flags about long-term spaceflight on the International Space Station (ISS), NASA officials were quoted as saying at the annual meeting of the American Association for the Advancement of Science here.

"It's almost as if the body's on high alert," said Christopher Mason, Associate Professor at Weill Cornell Medicine.

The space sojourn also changed the activity of some of his genes.

"It's mostly really good news," Mason said, adding, "the body has extraordinary plasticity and adaptation to being in zero gravity, at least for a year".

According to Craig Kundrot, Director of NASA's space life and physical sciences division, so far the space agency's research found nothing that would make a Mars mission impossible.

According to report, the biggest concern is radiation as such a mission would expose astronauts to levels of radiation greater than permitted under current guidelines. That would not necessarily prevent a mission, but it remains a concern.

However, Kundrot cautioned that the twin study has only two people as samples. "We don't regard any of this as conclusive, but on the whole it's encouraging," he said, adding, "there are no new major warning signs".

--IANS

rt/mag/soni/

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Feb 16 2019 | 12:52 PM IST

Next Story